{"name":"Extend Biosciences Inc.","slug":"extend-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EXT608","genericName":"EXT608","slug":"ext608","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"EXT608","genericName":"EXT608","slug":"ext608","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPcXk5M1E0eUVvTlZqaDdkY1NKREtLTHdLeVljVnR4Yk9HeVI3R1JjbDJwcFZZdTJRbDRXUGxUZVh5YWp4SEowU3p6bWNpdVZ5M29nNXdkWXRsTkp1Rm5EWDh2d3FVb3kyM25CcWExdnFqb2wwWVlvVlpXYUNkQzU3QWZaUnFIU0F4TnVaczZsekpmbllaUVdKcm5uY25nbnZDR1lkaHZDU2xtUFpyRG5tQmkzZURhZ0NLajVzdm1nY25vRWVGaGo1dmdKVXpMMmFRNEJsSjVOVQ?oc=5","date":"2026-04-01","type":"pipeline","source":"BioPharma APAC","summary":"NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development - BioPharma APAC","headline":"NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNa1BiOGVyb3dtTUFfTmhLRDVrQVpVc2lmUzRjbWdLREF6S19yZGx4RlZoZ3lmWjZqUE4teUQ2RlVRVjB2cDJ3RXdsaUd1U1FqLS02WVF5eWl3LU1td0c3ZHdqZEhIeUpsREcyRFZaaGRHVklOS3RxVXEzejdkcndtTFdZOHRMVGVOdEwyZVV2RkVzanN4RHBpWmFYZXE2dTkxenEwTURwUjE?oc=5","date":"2026-03-26","type":"pipeline","source":"Contract Pharma","summary":"Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO - Contract Pharma","headline":"Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE0zMjVrdVpqQU40Z1p6Tm5vMUctWXNuMTU4V2loV2IzMXVzZWNQRDY1UlMzVlp4VGJtaDVHdVUzRWxpeXZWVTA0UWRycHlpa1ZHS0dRTUNBTEpoamM5RGctLU05WEtZY0VaU0QtNWRXX3pweXUyQnc?oc=5","date":"2026-03-16","type":"pipeline","source":"labiotech.eu","summary":"13 anti-aging biotech companies to watch in 2026 - labiotech.eu","headline":"13 anti-aging biotech companies to watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPMXhtV2tzSHNkWDJrSVBmbG4yZUQtcjdtMkJSbk8ybVJXdFZER3lxdnU0RUp0ODE2Vk84WG5DRVg2MldxVHRza2ZURkVCYlBfbEV6NjROS1h5RFE2WGxkdEJnR2tPTnZqNTZ4bEdkdGMtcDFhU2RNSGtpWUxSdGVnYXJtNnIwUQ?oc=5","date":"2026-02-02","type":"deal","source":"Contract Pharma","summary":"SEQSTER, Praxis Extend Partnership - Contract Pharma","headline":"SEQSTER, Praxis Extend Partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOMXZYRXlHNFBiOWZiZ3R5NlRENUhaaHFRQndVRklqejhaZ3FxY2pKRXpEeGtTZ0ZvZ0hReDJpT09LdXRXZk4xa0JtWllRbGZnNDFQTlFMX2lsemxYbnk1WEFXVENta19oXzRiT3pnRG96SFRCenpTVi03aVdueDZ3aGhLTzRCUQ?oc=5","date":"2026-01-07","type":"pipeline","source":"Yahoo Finance","summary":"Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It - Yahoo Finance","headline":"Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1UeEp3eTQ0ZXBZUlRFSEhrc1VpS0QyOGV2dEpVS1ZYMVJIT3kyNm0xNDdhQjU2cEtTd0xHWnF3MHdyNjBKd3k4eXR6cll0OXduaHYwTHZnQUpMeXNac3E0N2t4TDYxdi1pVTFxV3ln?oc=5","date":"2025-12-23","type":"pipeline","source":"팜이데일리","summary":"Rznomics extends rally, shares up 576% from IPO price[K-Bio Pulse] - 팜이데일리","headline":"Rznomics extends rally, shares up 576% from IPO price[K-Bio Pulse] - 팜이데일리","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQNmxvNXVDQlNLWl9ZUng0QmJSSk44SENDcnRnQTQ2UGpESUV0X2RobHE2Njg2LXMxTC1nQXRHNXZDR21DanNldEJCcU54ZmZ5TnN0Y1RrVUhCRno4NXVMM2dOOXVObFJXUW8wSDM2ZmxTVzRqZlhqNURfMTZyY3AtQW9pN3VuRFJKNTZQN0I2LUdjMlVOQXp2cFZ0ckRYa05WUy1XbWpRYUZzd25uMDd1VGJEcnhfSnNkZE5ibG9MTU5ybnQ0RU94TmpQbnF6b3NOa195ZVRoSTVPZll5Y1E4cWhyZm41Um43a1I0MEQ1UkM5d3dpWTNnV2d4YTRZVmJXaVNPeXI5UVV6Nmt3dm9kZ1RxVEwwZ0UydV91Qi1LeEZVenp6UnMwZkxTRnhhT3hL?oc=5","date":"2025-11-19","type":"pipeline","source":"GlobeNewswire","summary":"Tempest Announces Strategic Acquisition of New Dual-CAR T - GlobeNewswire","headline":"Tempest Announces Strategic Acquisition of New Dual-CAR T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQkZRdEIybkRBQ0JHcWlhb010bjVGV3JndF9aWkJvUWNWdWZ1OHBJc0gxdFR5MHJTdjFfdERLT0hUUGIxMTFlLUhvNzJVVVJhMGVUaVJhNU5WNWNvREtBaFlqd0E2NlRjMk9FbEpNLV83Y0hUenNscTFUMmpTWm13bUdvNTgxQmpVcjRTZkpwUndrZnExNXBWUkpHd05fZDZFQ0dJNXhvd3R3SFdpOGJNNV9ON3g2ZVcwOHNV?oc=5","date":"2025-09-03","type":"pipeline","source":"Fierce Biotech","summary":"Treeline reaps $200M series A extension, plucks first 3 clinical candidates - Fierce Biotech","headline":"Treeline reaps $200M series A extension, plucks first 3 clinical candidates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNOUZmWlE2X3k3MWdGS0tBRjZ2RmRyYThtRG5BOWo3dnhlX2dPdWt0UFRkZTVjanlWRTlQRkIxdDBBLXN3bklTdjB4MDFnQjJBWFBSWE1nRGduZ0hrcW9ZUmN6VWdmZVhuMWd4Mm94bE04R0NGS2kzWDJuQmx2UllsbDB3bFdLUHRsTUZmUXR0M3NDMzVrSV82ZUJJSDJxZ1kwZGNPMktxeHktWVgwZ1YxMnRKQTVHdF9mX2c?oc=5","date":"2025-08-22","type":"patent","source":"prnewswire.com","summary":"Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab - prnewswire.com","headline":"Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOGZ0azlUZ0Zlam02TnFvZnJuZGtVVzBTUDJ3Z3dObkEwTk1MRGpMYkNHdGVJTUwzWTdFaE11X0VPUXJ2ZkdidE9HVDR3U3ljT0pYYWV6eXpyU3QtNS1UVy02UU54MklrNlA2SURqSEhHVUJZNTA4VDU5clBMekIzSTQwLU1uZGZzSXdSR3E1ampHS0hGOUgzMmVZT0JtMjYzQ3g5TUdKYkl6QQ?oc=5","date":"2025-08-14","type":"pipeline","source":"Pharmaceutical Executive","summary":"Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize - Pharmaceutical Executive","headline":"Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQcG41ODVoN3ZlMzRNWk1yMzZmOFdGMGdHZFZ0bVgydmVwZ0pPV1JMRnVFWmRGUkszQWIySTgtMExlenpRcU1YRVl3V2pHTzQxMG5UeXU4TTVwY096eXFhLWdBOS0yc2NRU2pfTEdydlh5dFFQWUF2OUlFNnFzaTVTRXgzUE5Lc0pKQ0QzQ01NLUN1UnR3dnlJOXEzUUh5VE5EZ1JzMUlFN0tldlNxQmozb1pKbV8tSGk3RHpWQ19mdzI4dzBQckNF?oc=5","date":"2025-05-13","type":"deal","source":"Fierce Pharma","summary":"Bluebird bio warns of potential bankruptcy as buyout faces another delay - Fierce Pharma","headline":"Bluebird bio warns of potential bankruptcy as buyout faces another delay","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}